Overview
- UnitedHealth reported second-quarter adjusted earnings per share of $4.08 on $111.6 billion in revenue, falling short of analysts’ forecasts.
- Its consolidated medical care ratio jumped to a record 89.4 percent as higher utilization and unit cost trends outpaced pricing.
- After suspending guidance in May, the insurer reinstated its 2025 outlook, cutting full-year adjusted EPS to at least $16 and revenue to $445.5 billion–$448 billion.
- In a recent SEC filing, UnitedHealth confirmed it is subject to criminal and civil Department of Justice investigations into its Medicare billing practices.
- Under CEO Stephen Hemsley, the company plans to exit select Medicare Advantage plans impacting over 600,000 members and intensify compliance reviews ahead of a targeted return to earnings growth in 2026.